UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000004749
Receipt No. R000005654
Scientific Title A study to evaluate the long-term effect of pulmonary hypertension on prognosis, activities of daily living (ADL), cardiac function and pulmonary function in patients with COPD and idiopathic pulmonary fibrosis (IPF), respectively, according to baseline severity of pulmonary hypertension and the efficacy and safety of the Tracleer (bosentan hydrate) tablet for prognosis, activities of daily living, cardiac function and pulmonary function in patients with COPD and IPF, respectively, according to baseline severity of pulmonary hypertension.
Date of disclosure of the study information 2010/12/18
Last modified on 2018/12/08 14:57:18

No. Disposal Last modified on Item of update
1 Insert 2010/12/18 08:57:51
2 Update 2011/06/18 12:41:56 Primary outcomes
Primary outcomes
Key secondary outcomes
Key secondary outcomes
3 Update 2011/06/18 12:49:38 Address
Address
Address
4 Update 2011/12/18 10:50:12 Post marketing survey by drug manufacture etc., specified by Japanese law.
Email1
5 Update 2011/12/22 15:47:44 Key secondary outcomes
Key secondary outcomes
6 Update 2012/12/18 14:54:41 Key inclusion criteria
Key inclusion criteria
7 Update 2012/12/19 13:27:22 Public title
Public title
Acronym
Acronym
8 Update 2012/12/19 13:32:27 Condition
Condition
Narrative objectives1
Narrative objectives1
9 Update 2012/12/19 13:37:51 Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_3
Interventions/Control_4
Interventions/Control_4
Interventions/Control_5
Interventions/Control_5
Interventions/Control_6
Interventions/Control_6
Key inclusion criteria
Key inclusion criteria
10 Update 2013/07/02 12:33:16 Key inclusion criteria
Key inclusion criteria
11 Update 2013/07/02 12:41:13 Primary outcomes
Primary outcomes
12 Update 2013/11/16 09:00:25 Email
Email
13 Update 2013/11/20 17:01:17 Randomization
Randomization unit
No. of arms
Interventions/Control_1
Interventions/Control_1
Interventions/Control_2
Interventions/Control_2
Interventions/Control_3
Interventions/Control_3
Interventions/Control_4
Interventions/Control_4
Interventions/Control_5
Interventions/Control_5
Interventions/Control_6
Interventions/Control_6
Interventions/Control_7
Interventions/Control_7
Interventions/Control_8
Interventions/Control_8
Interventions/Control_9
Interventions/Control_9
Interventions/Control_10
Interventions/Control_10
Key inclusion criteria
Key inclusion criteria
Target sample size
14 Update 2013/11/21 13:12:03 Control
Interventions/Control_1
Interventions/Control_1
Interventions/Control_2
Interventions/Control_2
Interventions/Control_3
Interventions/Control_3
Interventions/Control_4
Interventions/Control_4
Interventions/Control_5
Interventions/Control_5
Interventions/Control_6
Interventions/Control_6
Interventions/Control_7
Interventions/Control_7
Interventions/Control_8
Interventions/Control_8
Interventions/Control_9
Interventions/Control_9
Interventions/Control_10
Interventions/Control_10
Key inclusion criteria
Key inclusion criteria
Target sample size
15 Update 2013/11/21 13:22:55 Condition
Condition
Narrative objectives1
Narrative objectives1
Primary outcomes
Key secondary outcomes
Key secondary outcomes
16 Update 2013/11/21 18:38:50 Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
17 Update 2013/11/21 18:41:52 Condition
Condition
18 Update 2013/12/18 09:19:53 Public title
19 Update 2013/12/18 10:09:37 Last follow-up date
20 Update 2015/02/17 12:11:42 Key secondary outcomes
Key secondary outcomes
21 Update 2015/02/17 12:15:53 Key exclusion criteria
Key exclusion criteria
22 Update 2015/02/17 12:25:42 Last follow-up date
23 Update 2015/03/09 12:57:26 Interventions/Control_1
Interventions/Control_1
Interventions/Control_2
Interventions/Control_2
Interventions/Control_3
Interventions/Control_3
Interventions/Control_4
Interventions/Control_4
Interventions/Control_7
Interventions/Control_7
Interventions/Control_8
Interventions/Control_8
Interventions/Control_9
Interventions/Control_9
Interventions/Control_10
Interventions/Control_10
24 Update 2015/03/09 13:10:24 Public title
25 Update 2015/03/10 07:56:27 Public title
Acronym
26 Update 2015/03/10 07:57:39 Acronym
27 Update 2015/04/23 13:04:54 Public title
Acronym
28 Update 2015/04/24 11:26:26 Key secondary outcomes
Key secondary outcomes
29 Update 2015/05/09 21:09:06 Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
30 Update 2016/03/10 11:26:21 Interventions/Control_2
Interventions/Control_4
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
31 Update 2016/07/06 10:31:51 Public title
Acronym
32 Update 2016/07/06 10:41:59 Name of primary sponsor
Organization
33 Update 2016/07/06 10:47:52 Narrative objectives1
34 Update 2016/07/06 10:59:03 Narrative objectives1
35 Update 2016/07/09 07:31:50 Public title
Acronym
36 Update 2017/07/24 18:51:13 Key inclusion criteria
Key inclusion criteria
37 Update 2017/09/24 21:52:10 Public title
38 Update 2017/09/28 08:35:39
Key inclusion criteria
Key inclusion criteria
39 Update 2018/11/02 09:47:12 Public title
Public title
Acronym
Acronym
40 Update 2018/11/02 10:07:42 Condition
Narrative objectives1
Narrative objectives1
Primary outcomes
Primary outcomes
Key secondary outcomes
Key secondary outcomes
41 Update 2018/11/02 20:51:59 Public title
Acronym
42 Update 2018/11/02 20:57:19 Condition
Narrative objectives1
43 Update 2018/11/02 21:26:41 No. of arms
Interventions/Control_1
Interventions/Control_1
Interventions/Control_2
Interventions/Control_2
Interventions/Control_3
Interventions/Control_3
Interventions/Control_4
Interventions/Control_4
Interventions/Control_5
Interventions/Control_5
Interventions/Control_6
Interventions/Control_6
Interventions/Control_7
Interventions/Control_7
Interventions/Control_8
Interventions/Control_8
Interventions/Control_9
Interventions/Control_9
Interventions/Control_10
Interventions/Control_10
Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
Target sample size
44 Update 2018/11/02 22:46:50 Key secondary outcomes
Key secondary outcomes
45 Update 2018/11/03 21:27:07 Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Key inclusion criteria
Key exclusion criteria
46 Update 2018/11/04 09:11:18 Key secondary outcomes
47 Update 2018/11/04 15:25:33 Narrative objectives1
48 Update 2018/11/04 15:33:18 Primary outcomes
Primary outcomes
Key secondary outcomes
Key secondary outcomes
49 Update 2018/11/04 15:35:39 Key secondary outcomes
50 Update 2018/11/04 15:48:38 Public title
Acronym
51 Update 2018/12/08 14:57:18 Public title
Acronym


Contact us.